首页 | 本学科首页   官方微博 | 高级检索  
     

病毒性心肌炎发病机制研究及其药物治疗进展
引用本文:李晓冬. 病毒性心肌炎发病机制研究及其药物治疗进展[J]. 海南医学院学报, 2012, 18(4): 574-576
作者姓名:李晓冬
作者单位:大连市儿童医院,辽宁大连,116012
基金项目:中国高校医学期刊临床专项资金项目
摘    要:病毒性心肌炎(VMC)是一种由多种致病因素所引起的复杂疾病,包括病毒感染对心肌的损害、细胞免疫以及多种细胞因子等介导的心肌损害和微血管损伤。近年来VMC的发病呈逐年上升趋势,其发病症状隐匿,且易发生心源性猝死,加重了其危害性。本文就急性VMC发病机制进行总结,同时回顾近年来VMC的治疗药物进展。

关 键 词:病毒性心肌炎  病毒感染  细胞免疫损伤  药物治疗

Progress of pathogenesis and treatment of viral myocarditis
LI Xiao-dong. Progress of pathogenesis and treatment of viral myocarditis[J]. Journal of Hainan Medical College, 2012, 18(4): 574-576
Authors:LI Xiao-dong
Affiliation:LI Xiao-dong (Children′s Hospital of Dalian,Dalian 116012,China)
Abstract:Viral myocarditis(VCM) is a complex disease caused by multiple pathogenetic factors,including viral infection,cell immunological factors,and multiply cytokine factors.In recent years,the incidence of acute viral myocarditis has been on rise.The symptoms of acute viral myocarditis are concealed,and is prone to result in cardiogenic sudden death,which makes it more lethal.This article summarized researches on the pathogenesis and the treatment of acute viral myocarditis.
Keywords:Viral myocarditis  Viral infection  Cellullar immunology injury  Drug treatment
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号